Prostate cancer is one of those things most men don’t think about until it hits close to home. But it’s common, affecting millions—and early detection can save lives. The cancer itself can be sneaky, ...
Gozetotide is a drug for diagnostic application in adults with prostate cancer. It is currently the only diagnostic agent that recognizes PSMA-positive prostate cancer and can therefore identify ...
Prostate cancer is a leading cause of cancer deaths in American men. Current treatments target the hormone testosterone, which prostate cancer cells need to grow. Unfortunately, prostate tumors ...
Androgen deprivation is the mainstay of advanced prostate cancer treatment. Despite initial responses ... offers some insights into identifying the best sequence of new drugs.
Compared to white men, Black men are at greater risk of prostate cancer, more likely to develop it earlier, and more likely to die from it. Earlier screening may be warranted. Dr. Sheel Patel ...
Cancer staging at diagnosis directly influences treatment options and survival rates. Localized cancers, contained within the prostate, offer better prognoses compared to metastasized cases.